Nachrichten zur Viking Therapeutics Inc. Aktie

Why Viking Therapeutics, Inc. (VKTX) Went Up On Wednesday?

We recently published a list of 10 Stocks Stand Strong Amid Cautious Market Environment. In this article, we are going…

Why Hims & Hers Health Stock Crushed Novo Nordisk and Viking Therapeutics Today

Two healthcare stocks in the white-hot weight-loss segment tanked on Monday as one of their rivals zoomed higher. The…

2 Stocks to Buy With Less Than $40

Some think investing in stocks requires substantial start-up capital, but thats false. Even with a modest sum, like $40, investors…

3 No-Brainer Healthcare Stocks to Buy With $200 Right Now

Healthcare stocks have something to offer every investor. If youre looking for high growth, you can try an innovative biotech…

Viking Therapeutics Aktie: Pipeline-Strategie aktualisiert

Charlotte, NC (www.aktiencheck.de) - Viking Therapeutics-Aktienanalyse von Truist: Aktuelle Bewertung Truist hat das Kursziel für die Aktie von Viking Therapeutics, Inc. (ISIN:…

Viking Therapeutics price target lowered to $96 from $109 at B. Riley

…

2 Stocks That Could Soar Again in 2025

Many companies in the biotech industry performed well last year. Two in particular stood out: Viking Therapeutics (NASDAQ: VKTX) and…

Has the Bubble Burst for Viking Therapeutics Stock?

The excitement surrounding Viking Therapeutics (NASDAQ: VKTX) stock has been dying down significantly lately. In six months, the stock has…

VKTXs Q4 Loss Wider Than Expected, Sales Nil, Stock Down 10%

Viking Therapeutics fourth-quarter earnings miss estimates. The decline in stock price was attributable to a lack of material updates on…

Wall Street Analysts Think Viking Therapeutics (VKTX) Is a Good Investment: Is It?

The average brokerage recommendation (ABR) for Viking Therapeutics (VKTX) is equivalent to a Buy. The overly optimistic recommendations of Wall…

Viking Therapeutics: Why The Oral VK2735 Phase 2 Readout Could Send The Stock Soaring

…

This Weight Loss Stock Could Soar Over 220%, According to Wall Street. Time to Buy?

Wall Street has high hopes for development-stage pharmaceutical company Viking Therapeutics.…

Viking Therapeutics Stock Before Q4 Earnings: To Buy or Not to Buy?

Since VKTX is devoid of marketed drugs, investors will focus on pipeline updates when it reports Q4 results next week.…

This Biotech Stock Soared 116% in 2024, but Is It a Buy in 2025?

One of the hottest growth areas in the healthcare landscape these days is the obesity drug market because of a…

Viking Therapeutics: The Turning Point Is Not Here Yet

…

Viking Therapeutics Aktie: Analysten sehen großes Potenzial dank VK2735

New York (www.aktiencheck.de) - Viking Therapeutics-Aktienanalyse von H.C. Wainwright & Co.: Rating und Kursziel Die Analysten von H.C. Wainwright bewerten die Aktie…

Is It Worth Investing in Viking Therapeutics (VKTX) Based on Wall Streets Bullish Views?

The average brokerage recommendation (ABR) for Viking Therapeutics (VKTX) is equivalent to a Buy. The overly optimistic recommendations of Wall…

Is It Worth Investing in Viking Therapeutics (VKTX) Based on Wall Streets Bullish Views?

The average brokerage recommendation (ABR) for Viking Therapeutics (VKTX) is equivalent to a Buy. The overly optimistic recommendations of Wall…

Why Viking Therapeutics Stock Popped, but Novo Nordisk and Hims & Hers Health Dropped Today

A shake-up may be brewing in the market for GLP-1 diet drugs Friday, and its making itself felt all across…

Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Dropped on Tuesday

Bad news for Eli Lilly (NYSE: LLY) stock dragged down shares of rival companies in the market for GLP-1 diet…

3 Mid-Cap Stocks That Could Take Off in 2025

Some of the best possible returns for investors come by not going after megacaps, but instead pursuing stocks that have…

Why Viking Therapeutics Stock Plummeted by 24% in December

Viking Therapeutics (NASDAQ: VKTX) didnt exactly capture investors hearts in the final month of 2024. The biotech companys share price…

Should You Buy the Dip on This High-Flying Stock?

Its been an excellent year for Viking Therapeutics (NASDAQ: VKTX), a mid-cap biotech company. Thanks to impressive mid-stage clinical results,…

VKTX Stock Loses More Than 20% in Six Months: Should You Buy the Dip?

Despite the rising competition in the obesity space, we believe that there is room for smaller biotechs like Viking Therapeutics…

3 Stocks That Could Be Monster Winners in 2025

What do many kids like most about the coming of a new year? The fireworks. Investors dont mind seeing some…

Viking Therapeutics Aktie: Kursanstieg nach Novo Nordisks Studiendaten

New York (www.aktiencheck.de) - Viking Therapeutics-Aktienanalyse von BTIG: Aktuelle Bewertung BTIG hat die "buy"-Empfehlung für die Aktie von Viking Therapeutics, Inc. (ISIN:…

Viking Therapeutics Aktie: Enttäuschende Ergebnisse von Novo Nordisks eröffnen Chancen für Wettbewerber

New York (www.aktiencheck.de) - Viking Therapeutics-Aktienanalyse von H.C. Wainwright & Co: Aktuelle Bewertung Die H.C. Wainwright-Analyse betont die positive Entwicklung von Viking…

Down 18% in 1 Day, Is Viking Therapeutics Stock in Trouble Due to Merck?

The weight-loss biotech Viking Therapeutics (NASDAQ: VKTX) saw its stock get absolutely slammed on Dec. 18, falling 18% as a…

My Top 10 Stocks to Buy for 2025

Its that time of year again. Im not referring to buying gifts and preparing holiday meals -- although that may…

Why Viking Therapeutics Tumbled by More Than 10% This Week

News of a fresh licensing deal by a well-capitalized rival sent Viking Therapeutics (NASDAQ: VKTX) stock into something of a…

Viking Therapeutics: Holiday Gift

…

Prediction: These Could Be the Best-Performing Pharma and Biotech Stocks Through 2030

Pharmaceutical and biotech stocks often are seen as steady and safe options for investors for one particular reason. Patients need…

2 Soaring Stocks That Could Climb 68% to 166% Higher in 2025, According to Wall Street

Its been a good year for the stock market as a whole and a tremendous year for a couple of…

Viking Therapeutics, Inc. (VKTX) Stock Moves -1.75%: What You Should Know

Viking Therapeutics, Inc. (VKTX) closed at $47.03 in the latest trading session, marking a -1.75% move from the prior day.…

Warning: This Skyrocketing Stock Has a Hidden Risk

One particular healthcare stock has shown its ability to soar on good news -- and its had plenty of it.…

Should You Forget Pfizer and Buy These Unstoppable Stocks Instead?

Things arent getting much better for Pfizer (NYSE: PFE). The company is still suffering from the significant drop in sales…

Viking Therapeutics Aktie: VK2735 könnte "Best-in-Class"-Profil erreichen

New York (www.aktiencheck.de) - Viking Therapeutics-Aktienanalyse von BTIG: 1. Überblick der Analyse Wettbewerbsumfeld: Eli Lillys Tirzepatid (Zepbound) hat in einer Phase-3b-Studie eine…

After Crashing 27% in the Past Month, Is Viking Therapeutics Stock a Bargain Buy Right Now?

Theres a growing number of companies entering the weight loss space, focusing on GLP-1 drugs which can be game changers…

Viking Therapeutics Aktie: Großes Marktpotenzial

Minneapolis (www.aktiencheck.de) - Viking Therapeutics-Aktienanalyse von Piper Sandler: Das Hauptargument von Piper Sandler für die positive Bewertung der Aktie von Viking…

Viking Therapeutics Aktie: VK2735 übertrifft Amgens MariTide in Gewichtsverlust-Studien - Kaufempfehlung bestätigt

New York (www.aktiencheck.de) - Viking Therapeutics-Aktienanalyse von H.C. Wainwright & Co: Aktuelle Bewertung Die Analysten von H.C. Wainwright & Co bestätigen das…

Viking Therapeutics: B. Riley empfiehlt mit 104 % Kurspotenzial den Kauf - Marktführerschaft in den Bereichen Adipositas- und Diabetes-Therapien könnte bevorstehen

Viking Therapeutics (VKTX) ist ein Biotech, welcher sich auf Stoffwechsel- und seltene Krankheiten spezialisiert hat. Ihr Fokus liegt darauf, sogenannte…

Billionaire Ken Griffin Invested $93 Million of Citadels Portfolio in a Stock That Could Rocket 105% Higher, According to a Wall Street Analyst

Ken Griffin started the Citadel hedge fund in 1990. In the third quarter, Griffin and Citadel more than tripled…

PTA-News: Small- & MicroCap Investment: Die +440 %-Chance: NurExone mit dreistelligem Gewinn wie Vera Therapeutics oder Viking Therapeutics?

DJ PTA-News: Small- & MicroCap Investment: Die +440 %-Chance: NurExone mit dreistelligem Gewinn wie Vera Therapeutics oder Viking Therapeutics? Unternehmensmitteilung…

dpa-AFX ProFeed